Aleteia logoAleteia logo
Wednesday 14 April |
Saint of the Day: Bl. Hadewych of Meer
home iconNews
line break icon

“Young blood” may help those with Alzheimer’s disease



J-P Mauro - published on 11/07/17

New research indicates that young human blood plasma may have rejuvenating effects.

Researchers from Stanford University have found that the infusion of plasma from the blood of young people may be beneficial for Alzheimer’s patients. They first became aware of this possibility after the publication of another study from Stanford, earlier this year, in which researchers injected older mice with young human blood plasma and saw rejuvenating effects.

This new, admittedly limited, study focused on 18 Alzheimer’s patients who received a plasma infusion from healthy young men. While the treatment did seem to perk some of them up, it did not have an effect on memory or thinking skills.

NBC news has the details of the research:

At first they did what’s called a blinded trial — treating half the patients with real plasma, and giving half the patients a sham infusion, with no one knowing which patient got the real treatment. Then they swapped the two sides. Later, because it was taking so much time and effort, they cut the trial to just nine people and all nine knew they were getting the real thing – a unit of plasma, once a week for a month, from healthy young men under the age of 30. There was no measurable effect on memory or thinking, the team told the Clinical Trials on Alzheimer’s Disease conference in Boston. But researcher, Dr. Sharon Sha, said on two measurements of function there was a difference in answers the caregivers gave on a questionnaire.

Dr. Sha, a researcher on the team, notes that while caregivers have noticed an increase in attention span and conversation participation, there is no indication that the therapy will reverse memory loss. She cautions patients from rushing into treatment before their study is complete.

“I worry that people would take this information and say, ‘I need to get this. I need to get young blood.’ It’s important to understand the science behind this first,” Sha said

Joe McCracken, vice president for development at Alkahest, the medical company which will be working to create a marketable treatment using young human plasma, is hopeful that this research may be applied in the near future. Alkahest will begin formal clinical trials with 40 patients next year.

Support Aleteia!

If you’re reading this article, it’s thanks to the generosity of people like you, who have made Aleteia possible.

Here are some numbers:

  • 20 million users around the world read every month
  • Aleteia is published every day in seven languages: English, French, Italian, Spanish, Portuguese, Polish, and Slovenian
  • Each month, readers view more than 50 million pages
  • Nearly 4 million people follow Aleteia on social media
  • Each month, we publish 2,450 articles and around 40 videos
  • We have 60 full time staff and approximately 400 collaborators (writers, translators, photographers, etc.)

As you can imagine, these numbers represent a lot of work. We need you.

Support Aleteia with as little as $1. It only takes a minute. Thank you!

Daily prayer
And today we celebrate...

Top 10
Fr Robert McTeigue, SJ
A simple test to see if you really believe Christ is risen
Cerith Gardiner
11 Interesting facts about the late Prince Philip
Fr. Patrick Briscoe, OP
St. Faustina’s coffee cup and lessons for Divine Mercy Sund...
Annalisa Teggi
Amputee from the waist down is thankful every day to be alive
Here’s how to celebrate Divine Mercy Sunday at home
Philip Kosloski
St. Padre Pio: His life, his miracles and his legacy
Zelda Caldwell
Mystery of crosses on walls of Church of the Holy Sepulchre may h...
See More
Get Aleteia delivered to your inbox. Subscribe here.